Coagulation Cascade Flashcards

1
Q

Where does the coagulation cascade happen

A

On the surface of activated platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How to measure the extrinsic pathway

A

Prothrombin time
International normalised ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What triggers the extrinsic pathway

A

Tissue injury
Tissue factor is released from the tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Main two components of the extrinsic pathway

A

Tissue factor and factor VII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Common pathway factors

A

X and V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Intrinsic pathway factor

A

XII, XI, IX, VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is the intrinsic pathway measured

A

APTT
Activated partial thromboplastin time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does the intrinsic pathway have a role in

A

Infection and inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does the common pathway do

A

Converts prothrombin to thrombin
Then thrombin converts fibrinogen to fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where is tissue factor found

A

It is a receptor found on fibroblasts and SMC and injured macrophages and monocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

First part of the extrinsic pathway

A

Injury exposes TF
Complex made with VII activated, Ca and phospholipids on the cell which exposed TF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does the TF-VIIa complex activate

A

IX and X
This activates the common pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What starts the intrinsic pathway

A

Contact activation with negatively charged surfaces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does contact activation happen on

A

Collagen
Prosthetic valves/glass or plastic tubes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What factors make up contact activation

A

XII, PreK, HMWK this makes a complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What factor does contact activation activate

A

The XII/PreK/HMWK complex activates XI this forms kallikrein and bradykinin formation and helps activate IX in the common pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What happens when you get deficiencies under XII and XI in the intrinsic pathway

A

No bleeding but prolongs lab results as the extrinsic pathway can still feed the common pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What makes the tenase complex

A

IX, VIII, Ca and phospholipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What activated the final common pathway

A

Prothrombinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What makes up prothrombinase

A

Xa,Va, calcium and phospholipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What does prothrombinase do

A

It activates prothrombin to thrombin
Which will convert fibrinogen to fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How does thrombin convert fibrinogen to fibrin

A

By activating FXIII with calcium
This cross links fibrin making it stronger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What provides positive feedback in the common pathway

A

Thrombin
Activates factors X, VIII, XI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

In vivo coagulation - 3 overlapping stages

A

Initiation: continuous low level activation of TF pathway on cells with TF
Amplification: everything comes together and is activated
Propagation: reactions on the surface of activated platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What happens to platelets during initiation

A

No platelets or vWF yet so no coagulation until there is an injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What happens in the initiation coagulation phase

A

TF and VII bind on cells with TF
Low level activation of tenase and prothrombinase so getting ready for cell injury but not enough thrombin is made for a clot to happen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Purpose of initiation

A

To get ready for tissue injury
Generating low levels of thrombin
No injury yet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What happens in the amplification phase

A

Injury happens
Platelets and vWF come in
Platelets are activated from the low level thrombin from initiation and collagen 
Thrombin activates X, VIII, XI too

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What happens in the propagation phase

A

Reactions happen on the surface of activated platelets
More tenase is made and more prothrombinase so you get more thrombin being made for the thrombin burst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What happens in a thrombin burst

A

Fibrinogen cleaved to fibrin
XIII activated to stabilise clot
Positive feedback on V,VIII,XI
Stops fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What happens if you don’t have enough thrombin

A

Fibrin strands are thin and weak
Fibrinolysis breaks it down easily through tissue movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Does the fibrin clot start strong

A

No, starts weak and strengths with FXIII and clot retraction of platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Tube collection in coagulation testing

A

Sodium Citrate tube
Anticoagulant to stop clotting and activation of platelets and factors
9:1 ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Sample type for plasma aggregometry

A

Centrifuged PRP plasma rich plasma

35
Q

Sample type for most tests in coagulation

A

Platelet poor plasma

36
Q

Sample problems can arise from

A

Too hot or cold
Incorrect volume
Clot, haemolysis, icterus
Traumatic venepuncture
Prolonged tourniquet leads to increased vWF/factor 8
Delayed testing as half lives
Order of draw
Drug history

37
Q

What pathway is TCT related too

A

Common pathway

38
Q

What is PT sensitive too

A

Deficiency in VII, X, V and lesser II

39
Q

Reagents for prothrombin time

A

Thromboplastin (TF reagent with phospholipids and anti heparin)
CaCl
Buffet

40
Q

What is in thromboplastin

A

Tissue factor reagent
Phospholipids
Anti heparin

41
Q

What is detected in PT

A

Fibrin formation using optical detection or electromechanical detection

42
Q

Clinical factors prolonging PT

A

Reduced vitamin K (liver disease, warfarin/anticoagulants, consumptive coagulopathy)
Thrombin and X inhibitor drugs like dabigatran
RARE factor deficiency - X, B, XII or inhibitor antibodies

43
Q

Technical factors prolonging PT

A

Cold activation of FVII
Clotted sample
Haemolysis
Additive ratio/sample volume
Heparin contamination
Old reagents
Delayed testing

44
Q

Steps of APTT

A
  1. 5 min Incubation of PPP with contact activators like silica or soy
  2. Phospholipids platelet substitute added as these reactions happen on platelets
  3. CaCl added for rapid coagulation
45
Q

What is APTT sensitive too

A

Deficiency of factors V, X, VIII, IX, XI, XII

46
Q

What is in the phospholipid platelet substitution used in APTT

A

Partial thromboplastin
NO TF
Point is to eliminate patient platelet variability
Buffer

47
Q

How is APTT measured

A

Measures fibrin formation
Decrease in optical transmittance/absorbance as clot forms
Electromagnetic detection

48
Q

Clinical factors prolonging APTT

A

Decreased coagulation factors (liver disease, VK deficiency, anticoagulants, consumptive coagulopathy, transfusions, factor deficiency)
Coagulation factors inhibitors (antibodies like in lupus)
CRP higher than 100 interferes

49
Q

Technical factors prolonging APTT

A

Clotted sample
Volume/ additive ratio
Heparin
Haemolysis
Turbidity
Thromboplasin nature
Delay in testing etc

50
Q

TCT method

A

PPP
Thrombin reagent with CaCl and buffer
Start timer and wait for clotting

51
Q

Principle of TCT

A

Add thrombin in excess and see how long it takes for a clot to form
Focusing on fibrinogen and heparin screening

52
Q

What affects TCT

A

Fibrinogen conc
Fibrin degradation products
Heparin (VERY SENSITIVE)
Thrombin inhibitor drugs like dabigatran

53
Q

List three anticoagulants which prolongs APTT

A

Heparin
Warfarin
Dabigatran

54
Q

What tests are performed as a duplicate assay

A

PT
APTT
TCT
FIBRINOGEN

55
Q

Fibrinogen method

A

PPP
4 different assays - we use Clauss

56
Q

What prolongs fibrinogen

A

DIC- consumption of fibrinogen
Liver disease
Fibrin degradation products
Thrombotic therapy
Hypo/dysfibrinogenaemia

57
Q

Correction studies are done on what

A

APTT and PT

58
Q

When are correctional studies done

A

On a prolonged APTT and PT

59
Q

Correctional study method

A

1:1 mix of normal plasma with patient plasma

60
Q

What happens if plasma is not corrected

A

Clotting time is still prolonged or only partially corrected means inhibitor is present like heparin,antibodies or dabigatran

61
Q

What happens if prolonged times are corrected

A

Patient has a factor deficiency

62
Q

What deficiency is haemophilia A

A

Factor VIII/8
X linked
De novo in 30%

63
Q

What is haemophilia B

A

Christmas Disease
FIX deficiency
X linked

64
Q

Haemophilia bleeding pattern

A

Spontaneous bleeding and bleeding into joints (haemarthrosis)

65
Q

Solutions to joint bleeding in harmony

A

Reconstructive joint surgery as cartilage eroded from constant bleeding leading to narrow joint space

66
Q

Haemophilia treatment depends on what

A

How severely deficient they are in the factor
If only less than 1% factor is there then severe
Above 5 is mild

67
Q

Haemophilia treatment

A

Factor concentrates (specific for each lacking factor)
Fibrinolytic inhibitor (tranexamin acid) = stops clot breakdown
DDAVP if mild haemophilia A

68
Q

What does DDAVP do

A

Boosts endogenous vWF release from EC so more factor 8 too

69
Q

Acquired coagulation disorders

A

Vitamin K deficiency
Liver disease
DIC
Anticoagulants
Factor inhibitor antibodies
Haemo dilution

70
Q

Vitamin K dependent factors

A

II, VII, IX, X
PROTEIN C AND S

71
Q

Vitamin K deficiency presentation

A

Normal platelet and fibrinogen
Prolonged APTT and PT

72
Q

Vitamin K deficiency treated with

A

Vitamin K
24h healed if liver good
If not only partial response

73
Q

Cause of vitamin K deficiency in premature babies

A

Liver not developed

74
Q

Cause of VK deficiency newborns

A

Vitamin K stores exhausted in 2-4 and nutritional issues and sick babie s

75
Q

Vitamin K deficiency in adults caused by

A

Not eating for a week as stores last a few weeks
Antibiotics (stops synthesis as microflora is altered)
Cirrhosis and biliary obstruction as VK is fat soluble
Small bowel obstruction
Malabsorption- pancreatitis coeliac

76
Q

How does liver disease impact coagulation

A

Low TPO= Thrombocytopenia/splenomegaly
Platelet dysfunction
Dysfibrinogenaemia
DIC released thromboplastin in vivo inducing coagulation
Reduced synthesis of coagulation factors, fibrinogen, vitamin K dependence ones are not carboxylated, antithrombin

77
Q

What is DIC

A

Disseminated intravascular coagulation

78
Q

What causes DIC

A

Gram neg sepsis infections
Carcinoma
APML
Placental abruption/amniotic fluid embolus
Widespread damage like hypothermia, snake venom, anaphylaxis

79
Q

What happens in DIC

A

Procoagulation materials released
Consumption of platelets in clotting and fibrin is deposited in microvasculature
Decreased in clotting factors and platelets
More fibrinolysis from thrombin and FDPs so D dimers made

80
Q

Complications of DIC

A

Fibrin deposition in glomeruli
Peripheral gangrene
Widespread purpura - meningococcal Sepsis and DIC

81
Q

DIC diagnosis

A

Bleeding from wounds restarts or increases
Low fibrinogen or falling
PT and APTT prolonged
Thrombocytopenia
Lots of D dimers in plasma/urine
RBC fragments

82
Q

DIC treatment

A

Treat underlying
If bleeding replace deficient factors using fresh frozen plasma/fibrinogen but sometimes this is a bad idea
Heparin to save limbs like in malaria
Protein C concentrate if meningococcal

83
Q

DIC factor deficiency

A

V and VIII

84
Q

Lupus anticoagulants

A

Antibody against proteins for phospholipids
Longer APTT and PT